Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 22, 1996

View Archived Issues

Antithrombotic/antiallergic agents from Terumo

Antidiabetic agents reported by Terumo

New carbapenems from Takeda

Otsuka describes novel cephems

Japanese researchers disclose anti-HIV agents

Antitumor lactam isolated by Japanese researchers

Mercian discloses novel mitomycin

Antiparkinsonian skin patch enters pivotal phase II trial

RA test from Hemagen Diagnostics cleared for marketing

LecTec cleared to proceed with clinical testing of smoking cessation product

New impotence treatment deemed approvable by FDA

Alkermes and Genentech expand collaboration for sustained-release human GH

MDV acquired by Alliance

Novavax reports progress on products for H. pylori infection

Theratechnologies and AEterna sign technology licensing agreement

Company Profile: Lexicon Genetics

Lamotrigine now available in France

Another French market introduction for Lescol

New market introduction for ReoPro

Company profile: Molecumetics

Candela laser systems approved in Japan

New target for drug-resistant tumors identified

Quidel and Bayer collaborate on diagnostic tests

LeukoSite and Warner-Lambert collaborate on drugs blocking the CCR5 receptor

Calcium channel blocker update

ACE inhibitor-AT antagonist combination therapy results presented at AHA congress

Interim clinical results with Ansan's cancer product

RESTORE trial results presented at AHA meeting

Guilford's orally active neuroimmunophilin highly effective in animal models of Parkinson's disease

NeoTherapeutics' lead small molecule advances toward clinical trials in AD

NCI sponsors clinical trials with Therion's prostate cancer vaccine

PDL anti-HBV antibody enters phase II

OraVax, bioMerieux licensing agreement for H. pylori diagnostic technology

FDA issues approvable letter for Nycomed diagnostic

Favorable phase I results reported for NC-100100

Cytel/Abbott collaboration reaches milestone

Chiroscience to acquire U.S. gene-based biotech company

Cortecs plans oral insulin studies in diabetic patients

IDEC to present final pivotal data on IDEC-C2B8

SKB to begin pivotal trials with antibody for RA

Genentech advances NGF through the clinical development pipeline

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...